Trying to separate three different claims about phenylpiracetam: that it is the right molecule, that it is the right dose, and that it does something useful.
What the racetam class does pharmacologically does not require the subjective effect to be large to be real.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Vivid dreams are reported widely and are not in the label because there is not really a label.
Would like a narrow answer rather than an enthusiastic one.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at. How long have you been on phenylpiracetam?
How long before you can reasonably say something is or is not doing anything?
What is the first thing you would read if you were starting from zero? Same for me with phenylpiracetam, unfortunately.
Nobody has ever been talked out of a stack by a stranger on the internet. Not on phenylpiracetam but the pattern is familiar.
Narrow conclusion.
Read methods.
A certificate of analysis answers one question and gets quoted as though it answers four. Same for me with phenylpiracetam, unfortunately.
I would take the narrow conclusion. Broad ones are more interesting and less true.
Baseline first.
A plausible mechanism is not an outcome, and this class is the textbook example.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Is a baseline blood test really necessary before starting something like this?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.